Literature DB >> 19432549

Experimental infection of human volunteers with Haemophilus ducreyi: fifteen years of clinical data and experience.

Diane M Janowicz1, Susan Ofner, Barry P Katz, Stanley M Spinola.   

Abstract

Haemophilus ducreyi causes chancroid, which facilitates transmission of human immunodeficiency virus type 1. To better understand the biology of H. ducreyi, we developed a human inoculation model. In the present article, we describe clinical outcomes for 267 volunteers who were infected with H. ducreyi. There was a relationship between papule formation and estimated delivered dose. The outcome (either pustule formation or resolution) of infected sites for a given subject was not independent; the most important determinants of pustule formation were sex and host effects. When 41 subjects were infected a second time, their outcomes segregated toward their initial outcome, confirming the host effect. Subjects with pustules developed local symptoms that required withdrawal from the study after a mean of 8.6 days. There were 191 volunteers who had tissue biopsy performed, 173 of whom were available for follow-up analysis; 28 (16.2%) of these developed hypertrophic scars, but the model was otherwise safe. Mutant-parent trials confirmed key features in H. ducreyi pathogenesis, and the model has provided an opportunity to study differential human susceptibility to a bacterial infection.

Entities:  

Mesh:

Year:  2009        PMID: 19432549      PMCID: PMC2682218          DOI: 10.1086/598966

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  49 in total

1.  The immune response to Haemophilus ducreyi resembles a delayed-type hypersensitivity reaction throughout experimental infection of human subjects.

Authors:  K L Palmer; C T Schnizlein-Bick; A Orazi; K John; C Y Chen; A F Hood; S M Spinola
Journal:  J Infect Dis       Date:  1998-12       Impact factor: 5.226

2.  Prevention of experimental Haemophilus ducreyi infection: a randomized, controlled clinical trial.

Authors:  A C Thornton; E M O'Mara; S J Sorensen; T J Hiltke; K Fortney; B Katz; R E Shoup; A F Hood; S M Spinola
Journal:  J Infect Dis       Date:  1998-06       Impact factor: 5.226

3.  Experimental human infection with Haemophilus ducreyi.

Authors:  S M Spinola; L M Wild; M A Apicella; A A Gaspari; A A Campagnari
Journal:  J Infect Dis       Date:  1994-05       Impact factor: 5.226

4.  Experimental infection of human volunteers with Haemophilus ducreyi does not confer protection against subsequent challenge.

Authors:  J A Al-Tawfiq; K L Palmer; C Y Chen; J C Haley; B P Katz; A F Hood; S M Spinola
Journal:  J Infect Dis       Date:  1999-05       Impact factor: 5.226

5.  Trafficking pathways and characterization of CD4 and CD8 cells recruited to the skin of humans experimentally infected with Haemophilus ducreyi.

Authors:  Tricia L Humphreys; Lee Ann Baldridge; Steven D Billings; James J Campbell; Stanley M Spinola
Journal:  Infect Immun       Date:  2005-07       Impact factor: 3.441

Review 6.  Chancroid and Haemophilus ducreyi: an update.

Authors:  D L Trees; S A Morse
Journal:  Clin Microbiol Rev       Date:  1995-07       Impact factor: 26.132

7.  Evaluation of an isogenic hemolysin-deficient mutant in the human model of Haemophilus ducreyi infection.

Authors:  K L Palmer; A C Thornton; K R Fortney; A F Hood; R S Munson; S M Spinola
Journal:  J Infect Dis       Date:  1998-07       Impact factor: 5.226

8.  Standardization of the experimental model of Haemophilus ducreyi infection in human subjects.

Authors:  J A Al-Tawfiq; A C Thornton; B P Katz; K R Fortney; K D Todd; A F Hood; S M Spinola
Journal:  J Infect Dis       Date:  1998-12       Impact factor: 5.226

Review 9.  Regulation of innate and adaptive immunity by the female sex hormones oestradiol and progesterone.

Authors:  Kenneth W Beagley; Christine M Gockel
Journal:  FEMS Immunol Med Microbiol       Date:  2003-08-18

Review 10.  Chancroid and Haemophilus ducreyi.

Authors:  S A Morse
Journal:  Clin Microbiol Rev       Date:  1989-04       Impact factor: 26.132

View more
  40 in total

1.  Sialylation of lipooligosaccharides is dispensable for the virulence of Haemophilus ducreyi in humans.

Authors:  Stanley M Spinola; Wei Li; Kate R Fortney; Diane M Janowicz; Beth Zwickl; Barry P Katz; Robert S Munson
Journal:  Infect Immun       Date:  2011-12-05       Impact factor: 3.441

2.  Deliberate Microbial Infection Research Reveals Limitations to Current Safety Protections of Healthy Human Subjects.

Authors:  David L Evers; Carol B Fowler; Jeffrey T Mason; Rebecca K Mimnall
Journal:  Sci Eng Ethics       Date:  2014-08-24       Impact factor: 3.525

3.  A new human colonization model for nontypeable Haemophilus influenzae.

Authors:  Stephen J Barenkamp
Journal:  J Infect Dis       Date:  2013-05-28       Impact factor: 5.226

4.  Haemophilus ducreyi infection induces activation of the NLRP3 inflammasome in nonpolarized but not in polarized human macrophages.

Authors:  Wei Li; Barry P Katz; Margaret E Bauer; Stanley M Spinola
Journal:  Infect Immun       Date:  2013-06-10       Impact factor: 3.441

5.  The Haemophilus ducreyi Fis protein is involved in controlling expression of the lspB-lspA2 operon and other virulence factors.

Authors:  Maria Labandeira-Rey; Dana A Dodd; Chad A Brautigam; Kate R Fortney; Stanley M Spinola; Eric J Hansen
Journal:  Infect Immun       Date:  2013-08-26       Impact factor: 3.441

6.  Role played by CD4+FOXP3+ regulatory T Cells in suppression of host responses to Haemophilus ducreyi during experimental infection of human volunteers.

Authors:  Wei Li; Klara Tenner-Racz; Paul Racz; Diane M Janowicz; Kate R Fortney; Barry P Katz; Stanley M Spinola
Journal:  J Infect Dis       Date:  2010-06-15       Impact factor: 5.226

7.  Haemophilus ducreyi lipooligosaccharides induce expression of the immunosuppressive enzyme indoleamine 2,3-dioxygenase via type I interferons and tumor necrosis factor alpha in human dendritic cells.

Authors:  Wei Li; Barry P Katz; Stanley M Spinola
Journal:  Infect Immun       Date:  2011-05-16       Impact factor: 3.441

8.  Haemophilus ducreyi-induced interleukin-10 promotes a mixed M1 and M2 activation program in human macrophages.

Authors:  Wei Li; Barry P Katz; Stanley M Spinola
Journal:  Infect Immun       Date:  2012-10-01       Impact factor: 3.441

9.  Haemophilus ducreyi SapA contributes to cathelicidin resistance and virulence in humans.

Authors:  Kristy L B Mount; Carisa A Townsend; Sherri D Rinker; Xiaoping Gu; Kate R Fortney; Beth W Zwickl; Diane M Janowicz; Stanley M Spinola; Barry P Katz; Margaret E Bauer
Journal:  Infect Immun       Date:  2010-01-19       Impact factor: 3.441

10.  Host Polymorphisms in TLR9 and IL10 Are Associated With the Outcomes of Experimental Haemophilus ducreyi Infection in Human Volunteers.

Authors:  Martin Singer; Wei Li; Servaas A Morré; Sander Ouburg; Stanley M Spinola
Journal:  J Infect Dis       Date:  2016-04-27       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.